367 related articles for article (PubMed ID: 37675163)
1. COVID-19 in patients with rheumatological diseases in the Eastern Province of Saudi Arabia.
Alqatari S; Nemer A; Hasan M; Bukhari R; Al Argan R; Al Khafaji D; Alwaheed A; Alzaki A; Al-Wazza M; Al Warthan S; Al Saeed A; Albeladi F; Almeer H; AlSulaiman R; Abu Quren A
J Med Life; 2023 Jun; 16(6):873-882. PubMed ID: 37675163
[TBL] [Abstract][Full Text] [Related]
2. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases.
Freites Nuñez DD; Leon L; Mucientes A; Rodriguez-Rodriguez L; Font Urgelles J; Madrid García A; Colomer JI; Jover JA; Fernandez-Gutierrez B; Abasolo L
Ann Rheum Dis; 2020 Nov; 79(11):1393-1399. PubMed ID: 32769150
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study.
Pablos JL; Galindo M; Carmona L; Lledó A; Retuerto M; Blanco R; Gonzalez-Gay MA; Martinez-Lopez D; Castrejón I; Alvaro-Gracia JM; Fernández Fernández D; Mera-Varela A; Manrique-Arija S; Mena Vázquez N; Fernandez-Nebro A; ;
Ann Rheum Dis; 2020 Dec; 79(12):1544-1549. PubMed ID: 32796045
[TBL] [Abstract][Full Text] [Related]
5. SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases.
Larionova R; Byvaltsev K; Kravtsova О; Takha E; Petrov S; Kazarian G; Valeeva A; Shuralev E; Mukminov M; Renaudineau Y; Arleevskaya M
J Transl Autoimmun; 2022; 5():100154. PubMed ID: 35434592
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 prognosis in systemic lupus erythematosus compared with rheumatoid arthritis and spondyloarthritis: results from the CONTROL-19 Study by the Italian Society for Rheumatology.
Scirocco C; Ferrigno S; Andreoli L; Fredi M; Lomater C; Moroni L; Mosca M; Raffeiner B; Carrara G; Landolfi G; Rozza D; Zanetti A; Scirè CA; Sebastiani GD
Lupus Sci Med; 2023 Oct; 10(2):. PubMed ID: 37848262
[TBL] [Abstract][Full Text] [Related]
7. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.
Gianfrancesco M; Hyrich KL; Al-Adely S; Carmona L; Danila MI; Gossec L; Izadi Z; Jacobsohn L; Katz P; Lawson-Tovey S; Mateus EF; Rush S; Schmajuk G; Simard J; Strangfeld A; Trupin L; Wysham KD; Bhana S; Costello W; Grainger R; Hausmann JS; Liew JW; Sirotich E; Sufka P; Wallace ZS; Yazdany J; Machado PM; Robinson PC;
Ann Rheum Dis; 2020 Jul; 79(7):859-866. PubMed ID: 32471903
[TBL] [Abstract][Full Text] [Related]
8. Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes.
Montero F; Martínez-Barrio J; Serrano-Benavente B; González T; Rivera J; Molina Collada J; Castrejón I; Álvaro-Gracia J
Rheumatol Int; 2020 Oct; 40(10):1593-1598. PubMed ID: 32794113
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Antibody Isotypes in Systemic Lupus Erythematosus Patients Prior to Vaccination: Associations With Disease Activity, Antinuclear Antibodies, and Immunomodulatory Drugs During the First Year of the Pandemic.
Sjöwall J; Azharuddin M; Frodlund M; Zhang Y; Sandner L; Dahle C; Hinkula J; Sjöwall C
Front Immunol; 2021; 12():724047. PubMed ID: 34512651
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases.
Pablos JL; Abasolo L; Alvaro-Gracia JM; Blanco FJ; Blanco R; Castrejón I; Fernandez-Fernandez D; Fernandez-Gutierrez B; Galindo-Izquierdo M; Gonzalez-Gay MA; Manrique-Arija S; Mena Vázquez N; Mera Varela A; Retuerto M; Seijas-Lopez A;
Ann Rheum Dis; 2020 Sep; 79(9):1170-1173. PubMed ID: 32532753
[TBL] [Abstract][Full Text] [Related]
11. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series.
Ferri C; Giuggioli D; Raimondo V; L'Andolina M; Tavoni A; Cecchetti R; Guiducci S; Ursini F; Caminiti M; Varcasia G; Gigliotti P; Pellegrini R; Olivo D; Colaci M; Murdaca G; Brittelli R; Mariano GP; Spinella A; Bellando-Randone S; Aiello V; Bilia S; Giannini D; Ferrari T; Caminiti R; Brusi V; Meliconi R; Fallahi P; Antonelli A;
Clin Rheumatol; 2020 Nov; 39(11):3195-3204. PubMed ID: 32852623
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies.
Reder AT; Centonze D; Naylor ML; Nagpal A; Rajbhandari R; Altincatal A; Kim M; Berdofe A; Radhakrishnan M; Jung E; Sandrock AW; Smirnakis K; Popescu C; de Moor C
CNS Drugs; 2021 Mar; 35(3):317-330. PubMed ID: 33743151
[TBL] [Abstract][Full Text] [Related]
14. Effect of hydroxychloroquine pre-exposure on infection with SARS-CoV-2 in rheumatic disease patients: a population-based cohort study.
Jung SY; Kim MS; Kim MC; Choi SH; Chung JW; Choi ST
Clin Microbiol Infect; 2021 Apr; 27(4):611-617. PubMed ID: 33316402
[TBL] [Abstract][Full Text] [Related]
15. Evolution of COVID-19 in patients with autoimmune rheumatic diseases.
Pang R; Zhao J; Gan Z; Hu Z; Xue X; Wu Y; Qiao Q; Zhong A; Xia X; Liao H; Wang Z; Zhang L
Aging (Albany NY); 2020 Dec; 12(23):23427-23435. PubMed ID: 33289698
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 Mortality in Patients with Rheumatic Diseases: A Real Concern.
Al-Adhoubi NK; Ali M; Wahshi HA; Salmi IA; Al-Balushi F; Lawati TA; Mohammed A; Muqbali AA; Kalbani HA; Al-Abrawi S; Khamis F
Curr Rheumatol Rev; 2022; 18(3):234-242. PubMed ID: 35418287
[TBL] [Abstract][Full Text] [Related]
17. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.
Hasseli R; Mueller-Ladner U; Schmeiser T; Hoyer BF; Krause A; Lorenz HM; Regierer AC; Richter JG; Strangfeld A; Voll RE; Pfeil A; Schulze-Koops H; Specker C
RMD Open; 2020 Sep; 6(2):. PubMed ID: 32878994
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological, clinical, and laboratory findings for patients of different age groups with confirmed coronavirus disease 2019 (COVID-19) in a hospital in Saudi Arabia.
Ibrahim ME; Al-Aklobi OS; Abomughaid MM; Al-Ghamdi MA
PLoS One; 2021; 16(4):e0250955. PubMed ID: 33914805
[TBL] [Abstract][Full Text] [Related]
19. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
20. Effects of Biologic Therapies on the Chance of COVID-19 Infection Among Rheumatoid Arthritis and Lupus Patients During the First Wave of the Pandemic.
Sahebari M; Mirfeizi Z; Hashemzadeh K; Salavati Nik E; Gholampoor Shamkani N
Arch Bone Jt Surg; 2022 Nov; 10(11):964-968. PubMed ID: 36561225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
